Precision Medicine in Oncology

Researchers Hope Single-Cell Tumor Immune Atlas Can Improve Predictions in Precision Oncology

October 26th 2021, 12:15pm

Article

A pan-cancer reference atlas provides a framework for an immune-based patient stratification that study authors expect to be predictive for patient prognosis and immunotherapy response at an elevated level after further studies.

Single-Cell RNA Sequencing May Lend Insights Into Lung Adenocarcinoma Prognosis

October 25th 2021, 7:30pm

Article

The report suggests factors besides molecular profiling can be helpful in patient stratification.

Dr Funmi Olopade on WISDOM During COVID-19: Reaching Participants We Thought We Couldn’t Reach

October 23rd 2021, 3:00pm

Video

The WISDOM study—Women Informed to Screen Depending On Measures of risk—was launched to test a personalized approach to screening compared to annual mammograms. Funmi Olopade, MD, FACP, is a professor of Medicine and Human Genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medical Center, and a co-investigator of WISDOM. She discussed how the COVID-19 pandemic actually helped increase participation in the WISDOM study and what it means for future trials.

Review: Era of Precision Medicine Dawning in Prostate Cancer

October 19th 2021, 4:30pm

Article

An analysis of the latest research finds a robust approach to understanding particular prostate cancers remains necessary to finding optimal treatment.

Building a Patient-Centered Cancer Center From the Ground Up

October 13th 2021, 2:17pm

Article

More Data Needed on Tissue-Agnostic Therapy Use in Breast Cancer

October 12th 2021, 4:45pm

Article

This new study concluded that the breast cancer space needs more data to evaluate if there is a place for tissue-agnostic treatments for these patients.

Study Probes Role of Epigenetics in Precision Medicine for Lung Cancer

October 11th 2021, 8:45pm

Article

New modeling could help explain why some patients develop resistance to tyrosine kinase inhibitors.

The Promise of Liquid Biopsies for Cancer Diagnosis

October 11th 2021, 12:00pm

Article

Providing Patients With Cancer Access to Affordable Housing During Treatment

October 7th 2021, 4:00pm

Article

Patients traveling for cancer treatment often incur financial burdens. The members of the Alliance of Dedicated Cancer Centers should play a role in mitigating housing-associated costs for patients during cancer treatment.

Abstracts at ASCO Quality Show Uptake of Rapid NGS, Biomarker Testing Across OneOncology

October 4th 2021, 1:30pm

Article